申请人:LIPFORD Grayson B.
公开号:US20140221646A1
公开(公告)日:2014-08-07
The present invention relates to a compound of Formula I:
or a pharmaceutically acceptable salt thereof, wherein the symbols are as defined in the specification; a pharmaceutical composition comprising the same; and a method for treating or preventing autoimmunity disease using the same.
本发明涉及以下式子的化合物I:或其药学上可接受的盐,其中符号如规范中定义;包含相同化合物的制药组合物;以及使用相同化合物治疗或预防自身免疫疾病的方法。